The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. Here’s what to know.
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season.
The updated mRNA vaccines, Comirnaty and Spikevax, were fully approved for people 12 years and older, while the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine were granted emergency authorization for children 6 months through 11 years of age, according to an FDA announcement released today.
The monovalent (single) vaccines are designed to target the Omicron variant KP.
